Zoloft (sertraline) works for roughly 40 to 60 percent of people who take it as a first-line treatment for depression, with 30 to 45 percent achieving full remission, meaning their symptoms resolve completely. Those numbers place it solidly in the middle of available antidepressants for raw effectiveness, but it stands out for tolerability: fewer people quit taking it due to side effects compared to most competitors.
Response Rates for Depression
When researchers talk about an antidepressant “working,” they usually mean two different things. A treatment response is at least a 50 percent reduction in symptom severity. Remission is the stronger goal: symptoms dropping into the normal range, essentially feeling like yourself again. For SSRIs as a class, response rates fall between 40 and 60 percent, and remission rates between 30 and 45 percent. That means even in the best case, roughly half of people taking sertraline for depression will need to try a different medication or add something else.
Remission matters more than response. People who improve but still carry residual symptoms are at higher risk for relapse and tend to have worse long-term outcomes. So if you’re on Zoloft and feel somewhat better but not well, that’s worth a conversation about adjusting your treatment rather than settling.
How It Compares to Other Antidepressants
A landmark analysis published in The Lancet compared 21 antidepressants across hundreds of clinical trials. In terms of pure effectiveness, escitalopram (Lexapro), mirtazapine, paroxetine (Paxil), and venlafaxine (Effexor) ranked among the strongest performers. Sertraline landed in the middle tier for efficacy, not the most powerful option but far from the weakest. Fluoxetine (Prozac), fluvoxamine, and trazodone were among the least effective.
Where sertraline genuinely shines is acceptability. It was one of only six antidepressants (alongside escitalopram, citalopram, fluoxetine, agomelatine, and vortioxetine) that patients were significantly less likely to stop taking because of side effects. That matters in practice. A medication you can tolerate for months is more effective in the real world than a stronger one you quit after three weeks. This combination of decent efficacy and strong tolerability is a big reason Zoloft is one of the most commonly prescribed antidepressants worldwide.
How Long It Takes to Work
You may notice subtle changes within the first one to two weeks. Sleep, energy, and appetite often improve first, before your mood does. Full therapeutic effects for depression typically take four to six weeks of consistent daily use. This is one of the hardest parts of starting an antidepressant: the early weeks can feel like nothing is happening, or side effects may appear before benefits do.
For OCD and PTSD, the timeline is longer. Meaningful improvement can take up to 12 weeks. For PMDD (premenstrual dysphoric disorder), the picture is different in the opposite direction: benefits can appear as early as the first menstrual cycle after starting treatment.
Does a Higher Dose Work Better?
For the most part, no. A large review of dose-response research found that the standard starting dose of 50 mg daily is the optimal dose for sertraline in depression. Higher doses (100 mg, 150 mg, 200 mg) did not consistently produce greater symptom relief. Some evidence suggested a curvilinear pattern for sertraline specifically, where efficacy increases slightly, peaks, then actually declines at the highest doses.
What higher doses reliably do produce is more side effects. Nausea, sexual dysfunction, fatigue, and anxiety all become more common as the dose climbs, and dropout rates increase. This doesn’t mean no one benefits from a dose increase. Individual responses vary, and your prescriber may have good reasons to try a higher dose. But the broad evidence says that if 50 mg isn’t working after a full trial period, switching medications or adding a second agent is often a better strategy than simply going higher.
Effectiveness for OCD
Sertraline is FDA-approved for obsessive-compulsive disorder, and clinical trial data shows it produces a statistically significant reduction in OCD symptom severity over 12 weeks. In one randomized trial, patients started with an average OCD severity score in the moderate-to-severe range and dropped to around 13 on the Yale-Brown scale, which falls into the mild category. That’s a meaningful shift in daily life, though it’s worth noting that most people with OCD still have some residual symptoms on medication alone. Combining sertraline with cognitive behavioral therapy, particularly exposure and response prevention, tends to produce better outcomes than medication by itself.
Effectiveness for PMDD
Zoloft is one of the few antidepressants specifically approved for PMDD, and it can be used in flexible ways. Some people take it daily throughout the month. Others take it only during the luteal phase (the two weeks before a period starts) and stop when menstruation begins. A third approach, symptom-onset dosing, means starting the medication only when premenstrual symptoms appear.
Research from a randomized trial of 184 women with PMDD found that symptom-onset dosing was particularly effective at reducing anger and irritability, which in turn improved relationship functioning. However, it didn’t significantly improve productivity or participation in social activities and hobbies. So sertraline helps with some dimensions of PMDD more than others, and the dosing strategy you choose may affect which symptoms improve most.
When the First Medication Doesn’t Work
If you’ve already tried one antidepressant without success and switch to sertraline, the odds are lower. In the well-known STAR*D study, which tracked real-world depression treatment through multiple steps, patients who failed their first SSRI and switched to sertraline achieved remission about 18 percent of the time. That’s not dramatically different from switching to bupropion (21 percent remission), and both options had similar tolerability. The broader takeaway is that second-line treatments work for fewer people, which is why many clinicians consider augmentation strategies, adding a second medication to the first, rather than a straight switch.
The numbers can feel discouraging, but context helps. Depression treatment is often a process of refinement rather than a single prescription. The majority of people who persist through adjustments eventually find an effective regimen, even if the first attempt doesn’t get them there.